Cellectar Biosciences CLRB
NASDAQ CLRB
$2.56 -0.03 (-1.16%)
As of: Aug 21, 2026 · 3:22 PM EDT

Cellectar Biosciences (CLRB) Other financing activities (2010 - 2025)

Cellectar Biosciences (CLRB) posted Other financing activities of $7.2 million for Q4 2025, down 58.76% sequentially from $17.6 million in Q3 2024.

Cellectar Biosciences (CLRB) Other financing activities (2010 - 2025) Analysis & Trends

Cellectar Biosciences has reported Other financing activities for 12 years, with the latest figure at $7.2 million in Q4 2025.

  • Quarterly Other financing activities changed N/A year-over-year to $7.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.8 million (down 59.61% YoY) and the FY2025 annual result came in at $7.2 million, down 88.21% from the prior year.
  • Other financing activities fell to $7.2 million in Q4 2025 per CLRB's latest filing, from $17.6 million in the prior quarter.
  • Over five years, Other financing activities peaked at $43.8 million in Q1 2024 and troughed at $1.0 in Q2 2024.
  • A 4-year average of $8.8 million and a median of $827462.5 in 2021 frame the typical range for Other financing activities.
  • The widest YoY moves for Other financing activities: up 1461648800.0% in 2024, down 4937.13% in 2024.
  • Over 4 years, Other financing activities stood at $1.2 million in 2021, then tumbled by 63.67% to $441001.0 in 2023, then jumped by 3882.16% to $17.6 million in 2024, then slumped by 58.76% to $7.2 million in 2025.
  • According to Business Quant data, Other financing activities over the past three periods registered $7.2 million, $17.6 million, and $1.0 for Q4 2025, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.03 Bn 131.18 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn
3 Argenx Se 64.93 Bn 59.75 Bn 1.37 Bn
4 Moderna 57.93 Bn 52.80 Bn 52.00 Mn
5 BeOne Medicines 41.95 Bn 36.86 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.51 Bn 28.20 Bn 992.69 Mn
7 BioNTech SE 28.00 Bn 9.60 Bn 668.28 Mn
8 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
9 Royalty Pharma 27.29 Bn 26.45 Bn -
10 Cellectar Biosciences 6.68 Mn 6.68 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 7.24 Mn
Dec 31, 2025 7.24 Mn
Sep 30, 2024 17.56 Mn
Sep 30, 2024 17.56 Mn
Jun 30, 2024 1.00
Jun 30, 2024 1.00
Mar 31, 2024 43.85 Mn
Mar 31, 2024 43.85 Mn
Dec 31, 2023 441,001.00
Dec 31, 2023 441,001.00
Sep 30, 2023 348,638.00
Sep 30, 2023 348,638.00
Mar 31, 2023 3.00
Mar 31, 2023 3.00
Mar 31, 2021 1.21 Mn
Mar 31, 2021 1.21 Mn
Dec 31, 2020 610,798.00
Dec 31, 2020 610,798.00
Sep 30, 2020 31,683.00
Sep 30, 2020 31,683.00